Delivery Order SPE2DB24D2105-SPE2DB25FAQFT
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $25,619.20 by the Defense Logistics Agency on July 18, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors. This firm fixed-price delivery order, which carries an ultimate completion date of July 21, 2025, represents a non-competitive set-aside transaction and will be performed at the company's Corporate Office location in Conshohocken, PA....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 14, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections. The contract, valued at $20,199.71, is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025. This award was made on a competitive basis with no set-aside designation and represents a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,162.70 by the Defense Logistics Agency on September 18, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pens. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be completed by September 19, 2025, with the place of performance located in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 22, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. This competitive award, valued at $7,167.84 with firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX. The ultimate completion date is set for September 23, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mounjaro 10 mg/0.5 mL pen injectors with a ceiling value of $1,285.13. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive procurement under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,182.67 on August 8, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 24, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors, with a ceiling value of $3,265.08. This is a firm fixed-price, non-competitive set-aside delivery order with an ultimate completion date of September 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on May 7, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors valued at $27,363.70, with completion scheduled for May 8, 2025. The order represents a firm fixed-price, competitively awarded delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. Performance will be...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $5,758.57 firm fixed-price delivery order on August 14, 2025, for Mounjaro 2.5 mg/0.5 mL pen injections, with an ultimate completion date of August 15, 2025. The contract, issued without set-aside designation, represents a competitively awarded procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $11,848.28 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors (0.5 ml). The contract was competitively awarded without set-aside designation and is scheduled for completion by September 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's existing Indefinite...
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB25FAQFTDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $28,786.43 by the Defense Logistics Agency on September 18, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injectors (0.5 ml). This competitive, firm fixed-price delivery order is non-set-aside and is scheduled for completion by September 19, 2025, with performance taking place at the company's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a GLP-1 receptor agonist medication used for diabetes management, representing one of the critical pharmaceutical commodities in the Department of Defense's medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities to support military healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. The award demonstrates AmerisourceBergen Drug Corp's established capability to fulfill federal medical procurement requirements through competitive processes and reflects its role as a critical vendor within the Defense Logistics Agency's pharmaceutical supply network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.8k | 9/18/25 |